SEC Form 4 · accession 0001390478-15-000003
SELLAS Life Sciences Group, Inc. · SLS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Margaret Kivinski
Officer — VP and General Counsel
Period of report
Jan 16, 2015
Accepted (ET)
Jan 20, 2015 · 7:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001390478
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $1.75 | Jan 16, 2015 | A | 50,000 | A | — | Jan 16, 2025 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1Granted pursuant to the Issuer's Amended and Restated 2007 Incentive Plan.
- F2The option will vest in 16 equal quarterly installments of 3,125 shares over four years beginning on the first quarterly anniversary of the grant date (i.e., January 16, 2015), provided, in each case, that the Reporting Person remains in the continuous employ of the Issuer through such quarterly anniversary date.